Results of a 2-arm Phase II study of 9-nitrocamptothecin in patients with advanced soft-tissue sarcomas-Reference-Cited by-同舟云学术

Results of a 2-arm Phase II study of 9-nitrocamptothecin in patients with advanced soft-tissue sarcomas

Published:2003-05-19 Issue:11 Volume:97 Page:2848-2852
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Patel Shreyaskumar R.,Beach Jennifer,Papadopoulos Nicholas,Burgess M. Andrew,Trent Jonathan,Jenkins Jan,Benjamin Robert S.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference12 articles.

1. Cancer Statistics, 2002

2. Dose-intensive chemotherapy for soft-tissue sarcomas. In: editor. American Society of Clinical Oncology educational booklet (Spring 2000). Baltimore: Lippincott-Williams and Wilkins, 2000: 453-457.

3. New agents in the treatment of soft-tissue sarcomas

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Role of Topoisomerase I Inhibitors for the Treatment of Mesenchymal Malignancies and Their Potential Future Use as Payload of Sarcoma-Specific Antibody-Drug Conjugates;Oncology Research and Treatment;2023-11-28

2. Anti Cancer: DNA Topoisomerase Inhibitors;Reference Module in Chemistry, Molecular Sciences and Chemical Engineering;2013

3. Testing new regimens in patients with advanced soft tissue sarcoma: analysis of publications from the last 10 years;Annals of Oncology;2011-06

4. Mapping the literature: Role of trabectedin as a new chemotherapy option in advanced pretreated soft tissue sarcoma;Drugs of Today;2009

5. Potential Combination Chemotherapy Approaches for Advanced Adult-Type Soft-Tissue Sarcoma;American Journal of Clinical Dermatology;2008